Literature DB >> 9063457

Interactions between ovine cathepsin L, cystatin C and alpha 2-macroglobulin. Potential role in the genital tract.

S Peloille1, A Esnard, J L Dacheux, F Guillou, F Gauthier, F Esnard.   

Abstract

The specific inhibitor of cysteine proteinases, cystatin C, was purified from ram rete testis fluid and the conditioned medium of Sertoli cells. This molecule associated with sheep liver cathepsin L at one of the fastest rates ever described for a proteinase/inhibitor interaction (1.75 +/- 0.20 x 10(8) M-1.s-1). But the association rate constant for the interaction of cathepsin L with alpha 2-macroglobulin, a non-specific inhibitor of proteinases, was also extremely high (8.8 +/- 0.75 x 10(6) M-1.s-1). Cathepsin L complexed with alpha 2-macroglobulin was protected from inhibition by type 2 and type 3 cystatins. The data indicate that cystatin C is the most potent inhibitor of cathepsin L in mammalian male genital tract fluids, whereas alpha 2-macroglobulin may act as a terminal acceptor of this enzyme. These inhibitors could therefore inhibit the activated form of procathepsin L which may appear during the complex process of spermatozoa production and maturation in the testis and epididymis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063457     DOI: 10.1111/j.1432-1033.1997.00140.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Normal sexual development and fertility in testatin knockout mice.

Authors:  Virpi Töhönen; Jessica Frygelius; Majid Mohammadieh; Ulrik Kvist; Lauri J Pelliniemi; Kevin O'Brien; Katarina Nordqvist; Anna Wedell
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 2.  Do molecular signals from the conceptus influence endometrium decidualization in rodents?

Authors:  Jennifer L Herington; Brent M Bany
Journal:  J Exp Zool B Mol Dev Evol       Date:  2009-12-15       Impact factor: 2.656

3.  Cystatin C and Seminal Parameter Evaluation in Patients with End-Stage Renal Disease.

Authors:  Gilmar Pereira Silva; Vitor Pereira Xavier Grangeiro; Carmelita Félix Dantas de Oliveira; Francisco Lima Neto
Journal:  Curr Urol       Date:  2020-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.